MEDIOS AG (ILM1.DE) Stock Fundamental Analysis
FRA:ILM1 - Deutsche Boerse Ag - DE000A1MMCC8 - Common Stock - Currency: EUR
Taking everything into account, ILM1 scores 4 out of 10 in our fundamental rating. ILM1 was compared to 26 industry peers in the Health Care Providers & Services industry. ILM1 scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ILM1 is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
ILM1 had positive earnings in the past year.
In the past year ILM1 had a positive cash flow from operations.
ILM1 had positive earnings in each of the past 5 years.
Of the past 5 years ILM1 4 years had a positive operating cash flow.
1.2 Ratios
ILM1's Return On Assets of 1.61% is on the low side compared to the rest of the industry. ILM1 is outperformed by 65.38% of its industry peers.
ILM1's Return On Equity of 2.89% is on the low side compared to the rest of the industry. ILM1 is outperformed by 69.23% of its industry peers.
Looking at the Return On Invested Capital, with a value of 3.03%, ILM1 is doing worse than 65.38% of the companies in the same industry.
ILM1 had an Average Return On Invested Capital over the past 3 years of 3.26%. This is below the industry average of 5.58%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.61% | ||
| ROE | 2.89% | ||
| ROIC | 3.03% |
ROA(3y)2.56%
ROA(5y)2.39%
ROE(3y)3.52%
ROE(5y)3.26%
ROIC(3y)3.26%
ROIC(5y)3.09%
1.3 Margins
ILM1 has a worse Profit Margin (0.78%) than 69.23% of its industry peers.
In the last couple of years the Profit Margin of ILM1 has declined.
With a Operating Margin value of 1.96%, ILM1 is not doing good in the industry: 76.92% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of ILM1 has declined.
With a Gross Margin value of 8.91%, ILM1 is not doing good in the industry: 80.77% of the companies in the same industry are doing better.
ILM1's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.96% | ||
| PM (TTM) | 0.78% | ||
| GM | 8.91% |
OM growth 3Y14.45%
OM growth 5Y-8.47%
PM growth 3Y6.91%
PM growth 5Y-18.81%
GM growth 3Y16.82%
GM growth 5Y4.08%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ILM1 is destroying value.
The number of shares outstanding for ILM1 has been increased compared to 1 year ago.
The number of shares outstanding for ILM1 has been increased compared to 5 years ago.
The debt/assets ratio for ILM1 is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 3.07 indicates that ILM1 is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.07, ILM1 belongs to the top of the industry, outperforming 92.31% of the companies in the same industry.
The Debt to FCF ratio of ILM1 is 8.28, which is on the high side as it means it would take ILM1, 8.28 years of fcf income to pay off all of its debts.
ILM1's Debt to FCF ratio of 8.28 is fine compared to the rest of the industry. ILM1 outperforms 61.54% of its industry peers.
A Debt/Equity ratio of 0.37 indicates that ILM1 is not too dependend on debt financing.
ILM1 has a Debt to Equity ratio of 0.37. This is amongst the best in the industry. ILM1 outperforms 88.46% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.37 | ||
| Debt/FCF | 8.28 | ||
| Altman-Z | 3.07 |
ROIC/WACC0.47
WACC6.51%
2.3 Liquidity
A Current Ratio of 1.96 indicates that ILM1 should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.96, ILM1 belongs to the top of the industry, outperforming 88.46% of the companies in the same industry.
A Quick Ratio of 1.42 indicates that ILM1 should not have too much problems paying its short term obligations.
ILM1 has a Quick ratio of 1.42. This is amongst the best in the industry. ILM1 outperforms 84.62% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.96 | ||
| Quick Ratio | 1.42 |
3. Growth
3.1 Past
The earnings per share for ILM1 have decreased strongly by -22.32% in the last year.
The Earnings Per Share has been decreasing by -5.00% on average over the past years.
Looking at the last year, ILM1 shows a small growth in Revenue. The Revenue has grown by 5.62% in the last year.
The Revenue has been growing by 29.51% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-22.32%
EPS 3Y11.33%
EPS 5Y-5%
EPS Q2Q%47.06%
Revenue 1Y (TTM)5.62%
Revenue growth 3Y11.53%
Revenue growth 5Y29.51%
Sales Q2Q%6.23%
3.2 Future
Based on estimates for the next years, ILM1 will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.69% on average per year.
Based on estimates for the next years, ILM1 will show a small growth in Revenue. The Revenue will grow by 4.11% on average per year.
EPS Next Y8.93%
EPS Next 2Y21.1%
EPS Next 3Y15.69%
EPS Next 5YN/A
Revenue Next Year8.23%
Revenue Next 2Y6.19%
Revenue Next 3Y5.81%
Revenue Next 5Y4.11%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 24.10, which indicates a rather expensive current valuation of ILM1.
Compared to the rest of the industry, the Price/Earnings ratio of ILM1 indicates a slightly more expensive valuation: ILM1 is more expensive than 61.54% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.87, ILM1 is valued at the same level.
A Price/Forward Earnings ratio of 9.59 indicates a reasonable valuation of ILM1.
88.46% of the companies in the same industry are more expensive than ILM1, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.34, ILM1 is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.1 | ||
| Fwd PE | 9.59 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ILM1 is valued a bit cheaper than 76.92% of the companies in the same industry.
ILM1's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. ILM1 is more expensive than 65.38% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.56 | ||
| EV/EBITDA | 6.78 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as ILM1's earnings are expected to grow with 15.69% in the coming years.
PEG (NY)2.7
PEG (5Y)N/A
EPS Next 2Y21.1%
EPS Next 3Y15.69%
5. Dividend
5.1 Amount
No dividends for ILM1!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:ILM1 (8/15/2025, 7:00:00 PM)
14.22
-0.28 (-1.93%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners35.03%
Inst Owner ChangeN/A
Ins Owners19.96%
Ins Owner ChangeN/A
Market Cap362.75M
Analysts85
Price Target28.08 (97.47%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.59%
Revenue NY rev (3m)0.59%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.1 | ||
| Fwd PE | 9.59 | ||
| P/S | 0.19 | ||
| P/FCF | 13.56 | ||
| P/OCF | 10.72 | ||
| P/B | 0.7 | ||
| P/tB | 26.46 | ||
| EV/EBITDA | 6.78 |
EPS(TTM)0.59
EY4.15%
EPS(NY)1.48
Fwd EY10.43%
FCF(TTM)1.05
FCFY7.38%
OCF(TTM)1.33
OCFY9.33%
SpS74.93
BVpS20.26
TBVpS0.54
PEG (NY)2.7
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.61% | ||
| ROE | 2.89% | ||
| ROCE | 4.99% | ||
| ROIC | 3.03% | ||
| ROICexc | 3.44% | ||
| ROICexgc | 14.41% | ||
| OM | 1.96% | ||
| PM (TTM) | 0.78% | ||
| GM | 8.91% | ||
| FCFM | 1.4% |
ROA(3y)2.56%
ROA(5y)2.39%
ROE(3y)3.52%
ROE(5y)3.26%
ROIC(3y)3.26%
ROIC(5y)3.09%
ROICexc(3y)3.82%
ROICexc(5y)3.8%
ROICexgc(3y)12.89%
ROICexgc(5y)11.48%
ROCE(3y)5.38%
ROCE(5y)5.1%
ROICexcg growth 3Y-0.85%
ROICexcg growth 5Y-8.22%
ROICexc growth 3Y-6.07%
ROICexc growth 5Y-23.77%
OM growth 3Y14.45%
OM growth 5Y-8.47%
PM growth 3Y6.91%
PM growth 5Y-18.81%
GM growth 3Y16.82%
GM growth 5Y4.08%
F-Score4
Asset Turnover2.06
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.37 | ||
| Debt/FCF | 8.28 | ||
| Debt/EBITDA | 2.61 | ||
| Cap/Depr | 19.94% | ||
| Cap/Sales | 0.37% | ||
| Interest Coverage | 2.86 | ||
| Cash Conversion | 46.37% | ||
| Profit Quality | 179.07% | ||
| Current Ratio | 1.96 | ||
| Quick Ratio | 1.42 | ||
| Altman-Z | 3.07 |
F-Score4
WACC6.51%
ROIC/WACC0.47
Cap/Depr(3y)16.31%
Cap/Depr(5y)50.4%
Cap/Sales(3y)0.24%
Cap/Sales(5y)0.49%
Profit Quality(3y)264.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.32%
EPS 3Y11.33%
EPS 5Y-5%
EPS Q2Q%47.06%
EPS Next Y8.93%
EPS Next 2Y21.1%
EPS Next 3Y15.69%
EPS Next 5YN/A
Revenue 1Y (TTM)5.62%
Revenue growth 3Y11.53%
Revenue growth 5Y29.51%
Sales Q2Q%6.23%
Revenue Next Year8.23%
Revenue Next 2Y6.19%
Revenue Next 3Y5.81%
Revenue Next 5Y4.11%
EBIT growth 1Y25.3%
EBIT growth 3Y27.64%
EBIT growth 5Y18.54%
EBIT Next Year110.41%
EBIT Next 3Y33.73%
EBIT Next 5Y29.68%
FCF growth 1Y140.67%
FCF growth 3Y11.42%
FCF growth 5YN/A
OCF growth 1Y136.45%
OCF growth 3Y6.19%
OCF growth 5YN/A